D6191
Dialysis sacks
MWCO 12,000 Da
Synonym(s):
Dialysis Bags, Dialysis Equipment
Sign Into View Organizational & Contract Pricing
Select a Size
25 EA
€114.00
€114.00
Please contact Customer Service for Availability
All Photos(1)
Select a Size
Change View
25 EA
€114.00
About This Item
UNSPSC Code:
41123100
NACRES:
NB.22
€114.00
Please contact Customer Service for Availability
Recommended Products
pore size
12,000 Da MWCO
Looking for similar products? Visit Product Comparison Guide
General description
Cellulose tubing; will retain proteins with M.W. > 12,000 Da
Inflated diam. approx. 16 mm (0.64 in.); pre-cut; open ended; dry, unwashed; approx. length = 30 cm (12 in.)
Storage Class Code
11 - Combustible Solids
WGK
WGK 1
Flash Point(F)
Not applicable
Flash Point(C)
Not applicable
Choose from one of the most recent versions:
Certificates of Analysis (COA)
Lot/Batch Number
It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.
If you need assistance, please contact Customer Support.
Already Own This Product?
Find documentation for the products that you have recently purchased in the Document Library.
Customers Also Viewed
McShane McKenna et al.
Frontiers in bioengineering and biotechnology, 8, 619252-619252 (2021-02-23)
Protein kinase B (AKT1) is hyper-activated in diverse human tumors. AKT1 is activated by phosphorylation at two key regulatory sites, Thr308 and Ser473. Active AKT1 phosphorylates many, perhaps hundreds, of downstream cellular targets in the cytosol and nucleus. AKT1 is
Atul Dev et al.
Phytomedicine : international journal of phytotherapy and phytopharmacology, 80, 153386-153386 (2020-10-29)
Overexpression of polycomb protein contributes to epigenetic repression in oral squamous cell carcinoma (OSCC) ensuing in poor prognosis and aggressive phenotype. Several plant-based compounds could help prevent epigenome alteration and cancer progression, but their low bioavailability limits their therapeutic activity.
Sumit Arora et al.
Molecular pharmaceutics, 12(6), 2001-2009 (2015-04-30)
The present research aimed to develop and characterize a sustained release dry powder inhalable formulation of voriconazole (VRZ) for invasive pulmonary aspergillosis. The developed formulations were studied for their in vitro release profile, aerosol, and physicochemical properties as well as
Related Content
Dialysis Tubing
Active Filters
Our team of scientists has experience in all areas of research including Life Science, Material Science, Chemical Synthesis, Chromatography, Analytical and many others.
Contact Technical Service
